# Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes

> **NCT01237301** · NA · COMPLETED · sponsor: **HealthPartners Institute** · enrollment: 124 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** CGM Group
- **DEVICE:** SMBG Group

## Key facts

- **NCT ID:** NCT01237301
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2018-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01237301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01237301, "Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01237301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*